The following is excerpted from a press release issued by Minimed.
“Achieving the endpoints of the in-clinic ASPIRE study is an important milestone toward FDA approval and bringing Low Glucose Suspend technology to the U.S. market,” said Dr. Francine Kaufman, Chief Medical Officer and Vice President of Global Clinical Affairs for the Diabetes business of Medtronic. “We are excited about this first step and are committed to advancing the insulin delivery, sensor technology, and closed loop algorithms to commercialize an artificial pancreas.”
The full press release can be read here. If anybody is able to get a copy of the published paper please add it.
Progress - it is a good thing.
That is great...I am one of those people that suffer frequent lows that come on rapidly..below 70 at least two or three times a week. I wondr how a perosn can get envolved in the study here?
Basic info on what the FDA is doing in this area can be found here. Specific news about advancements is here and it seems the bulk of the work is being done at the University of Virginia and the University of California at Santa Barbara.
A great place to see some of the clinical trials going on that pertain to Type I Diabetes is found on a web site called Center Watch.